A Multi-Institutional Prospective Trial Confirms Noninvasive Blood Test Maintains Predictive Value in African American Men-Reference-Cited by-同舟云学术

A Multi-Institutional Prospective Trial Confirms Noninvasive Blood Test Maintains Predictive Value in African American Men

Published:2018-06 Issue:6 Volume:199 Page:1459-1463
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Punnen Sanoj¹,Freedland Stephen J.²³,Polascik Thomas J.³⁴,Loeb Stacy⁵,Risk Michael C.⁶,Savage Stephen⁷,Mathur Sharad C.⁸,Uchio Edward⁹¹⁰,Dong Yan¹¹,Silberstein Jonathan L.¹²

Affiliation:

1. Department of Urology, University of Miami and Miami Veterans Affairs Medical Center, Miami, Florida

2. Cedars-Sinai Medical Center, Los Angeles, California

3. Durham Veterans Affairs Medical Center, Durham, North Carolina

4. Duke Cancer Institute, Durham, North Carolina

5. Department of Urology and Population Health, New York University and Manhattan Veterans Affairs Medical Center, New York, New York

6. Department of Urology, University of Minnesota and Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota

7. Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina

8. Pathology and Laboratory Medicine Service, Kansas City Veterans Affairs Medical Center, Kansas City, Missouri

9. Department of Urology, University of California-Irvine, Irvine, California

10. Veterans Affairs Long Beach Health System, Long Beach, California

11. OPKO Diagnostics, Woburn, Massachusetts

12. Tulane University School of Medicine and Southeast Louisiana Veterans Health Care Center, New Orleans, Louisiana

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference18 articles.

1. A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer;Parekh;Eur Urol,2015

2. Predicting high-grade cancer at ten-core prostate biopsy using four kallikrein markers measured in blood in the ProtecT study;Bryant;J Natl Cancer Inst,2015

3. A four-kallikrein panel predicts high-grade cancer on biopsy: independent validation in a community cohort;Braun;Eur Urol,2016

4. Improving the specificity of screening for lethal prostate cancer using prostate-specific antigen and a panel of kallikrein markers: a nested case-control study;Stattin;Eur Urol,2015

5. The 4Kscore® test reduces prostate biopsy rates in community and academic urology practices;Konety;Rev Urol,2015

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stockholm3 in a Multiethnic Cohort for Prostate Cancer Detection (SEPTA): A Prospective Multicentered Trial;Journal of Clinical Oncology;2024-07-22

2. Evaluation of blood and urine based biomarkers for detection of clinically-significant prostate cancer;Prostate Cancer and Prostatic Diseases;2024-06-10

3. Established and emerging liquid biomarkers for prostate cancer detection: A review;Urologic Oncology: Seminars and Original Investigations;2024-06

4. Prostate cancer biomarkers: from early diagnosis to precision treatment;Clinical and Translational Oncology;2024-05-14

5. Liquid Biomarkers in Prostate Cancer Diagnosis: Current Status and Emerging Prospects;The World Journal of Men's Health;2024